TORONTO, Dec. 1, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. (“Transition” or the “Company”) (TSX:TTH.TO - News) (Nasdaq:TTHI - News), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended September 30, 2011.
